Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-002484
Filing Date
2025-01-06
Accepted
2025-01-06 20:14:08
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3549
  Complete submission text file 0000950170-25-002484.txt   4994
Mailing Address C/O AMBRX, INC. 10975 N. TORREY PINES RD. LA JOLLA CA 92037
Business Address
MACARTNEY LAWSON (Reporting) CIK: 0001606831 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37355 | Film No.: 25513176

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)